| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Chief Commercial & Medical Affairs Officer | Common Stock | 285,160 | $1,083,608 | $3.80 | 11 Feb 2026 | Direct |
| ROCKET PHARMACEUTICALS, INC. | Chief Commercial & Medical Affairs Officer | Stock Option (Right to Buy) | 189,076 | 11 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | 11 Feb 2026 | 2 | $0 | 4 | Chief Commercial & Medical Affairs Officer | 13 Feb 2026, 16:05 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 07 Apr 2025 | 0 | $0 | 3 | Chief Commercial & Medical Affairs Officer Exhibit 24: Power of Attorney | 22 Apr 2025, 16:05 |